Literature DB >> 16575378

Antidepressants and cognitive-behavioral therapy for symptom syndromes.

Jeffrey L Jackson1, Patrick G O'Malley, Kurt Kroenke.   

Abstract

Somatic symptoms are common in primary care and clinicians often prescribe antidepressants as adjunctive therapy. There are many possible reasons why this may work, including treating comorbid depression or anxiety, inhibition of ascending pain pathways, inhibition of prefrontal cortical areas that are responsible for "attention" to noxious stimuli, and the direct effects of the medications on the syndrome. There are good theoretical reasons why antidepressants with balanced norepinephrine and serotonin effects may be more effective than those that act predominantly on one pathway, though head-to-head comparisons are lacking. For the 11 painful syndromes review in this article, cognitive-behavioral therapy is most consistently demonstrated to be effective, with various antidepressants having more or less randomized controlled data supporting or refuting effectiveness. This article reviews the randomized controlled trial data for the use of antidepressant and cognitive-behavior therapy for 11 somatic syndromes: irritable bowel syndrome, chronic back pain, headache, fibromyalgia, chronic fatigue syndrome, tinnitus, menopausal symptoms, chronic facial pain, noncardiac chest pain, interstitial cystitis, and chronic pelvic pain. For some syndromes, the data for or against treatment effectiveness is relatively robust, for many, however, the data, one way or the other is scanty.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16575378     DOI: 10.1017/s1092852900014383

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  23 in total

1.  [Somatoform disorders. Clinical evidence, etiology, pathogenesis, and therapy].

Authors:  H P Kapfhammer
Journal:  Nervenarzt       Date:  2008-01       Impact factor: 1.214

Review 2.  Pharmacological and psychosocial management of mental, neurological and substance use disorders in low- and middle-income countries: issues and current strategies.

Authors:  Jair de Jesus Mari; Luís Fernando Tófoli; Cristiano Noto; Li M Li; Alessandra Diehl; Angélica M Claudino; Mario F Juruena
Journal:  Drugs       Date:  2013-09       Impact factor: 9.546

3.  Tinnitus, Traumatic Brain Injury, and Posttraumatic Stress Disorder in the Military.

Authors:  John C Moring; Alan L Peterson; Kathryn E Kanzler
Journal:  Int J Behav Med       Date:  2018-06

Review 4.  Pragmatic characteristics of patient-reported outcome measures are important for use in clinical practice.

Authors:  Kurt Kroenke; Patrick O Monahan; Jacob Kean
Journal:  J Clin Epidemiol       Date:  2015-04-11       Impact factor: 6.437

5.  The SPADE Symptom Cluster in Primary Care Patients With Chronic Pain.

Authors:  Lorie L Davis; Kurt Kroenke; Patrick Monahan; Jacob Kean; Timothy E Stump
Journal:  Clin J Pain       Date:  2016-05       Impact factor: 3.442

6.  Pilot pharmacologic randomized controlled trial for psychogenic nonepileptic seizures.

Authors:  W C LaFrance; G I Keitner; G D Papandonatos; A S Blum; J T Machan; C E Ryan; I W Miller
Journal:  Neurology       Date:  2010-08-25       Impact factor: 9.910

7.  Reciprocal relationship between pain and depression: a 12-month longitudinal analysis in primary care.

Authors:  Kurt Kroenke; Jingwei Wu; Matthew J Bair; Erin E Krebs; Teresa M Damush; Wanzhu Tu
Journal:  J Pain       Date:  2011-06-16       Impact factor: 5.820

8.  Venlafaxine versus mirtazapine in the treatment of undifferentiated somatoform disorder: a 12-week prospective, open-label, randomized, parallel-group trial.

Authors:  Changsu Han; Chi-Un Pae; Bun-Hee Lee; Young-Hoon Ko; Prakash S Masand; Ashwin A Patkar; Sook-Haeng Joe; In-Kwa Jung
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

9.  Psychosocial stress and anxiety in musculoskeletal pain patients with and without depression.

Authors:  Ellen L Poleshuck; Matthew J Bair; Kurt Kroenke; Teresa M Damush; Wanzhu Tu; Jingwei Wu; Erin E Krebs; Donna E Giles
Journal:  Gen Hosp Psychiatry       Date:  2008-11-22       Impact factor: 3.238

10.  Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial.

Authors:  Kurt Kroenke; Matthew J Bair; Teresa M Damush; Jingwei Wu; Shawn Hoke; Jason Sutherland; Wanzhu Tu
Journal:  JAMA       Date:  2009-05-27       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.